Sanofi Pasteur 545-03 ActHIB Haemophilus Influenzae Type b Vaccine (Hib) Indicated for People 2 Months to 5 Years of Age 10 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

ActHIB is a vaccine indicated for the prevention of invasive disease caused by Haemophilus influenzae type b
ActHIB vaccine is approved for use as a four dose series in infants and children 2 months through 5 years of age

Manufacturer # 545-03
Brand ActHIB®
Manufacturer Sanofi Pasteur
Country of Origin France
Application Haemophilus Influenzae Type b Vaccine (Hib)
Container Type Single-Dose Vial
Dosage Form Injection
Generic Drug Code 99298
Generic Drug Name Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), Preservative Free
Is_Active_Vendor Y
Is_DSCSA Y
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag Y
NDC Number 49281054503
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires Refrigeration
Strength 10 mcg / 0.5 mL
Supplier_ID 488026
Type Intramuscular
UNSPSC Code 51201627
User Indicated for People 2 Months to 5 Years of Age
Volume 0.5 mL